AeroVironment vs. Kratos Defense: Which Drone Defense Stock Is Better?

Key metrics: AeroVironment’s fiscal 2026 EPS consensus fell 12.68% in the past 60 days while Kratos’s 2026 EPS consensus rose 5.48%; ROE is 3.26% for AVAV vs 4.96% for KTOS; one-year returns are +54.7% (AVAV) and +142.3% (KTOS); P/S F12M multiples are 4.26 (AVAV) and 7.68 (KTOS). Zacks ranks AVAV #5 (Strong Sell) and KTOS #3 (Hold). Conclusion: the article favors Kratos based on stronger price performance, an improving earnings outlook and relatively better ROE.

Analysis

Market pricing currently embeds a divergence between visible execution and optionality: one name is being rewarded for demonstrable, near-term production scale while the other is being discounted for hit-or-miss revenue and margin recovery. That gap creates a tactical arbitrage — not because the underlying TAM is different, but because capital intensity and contract visibility differ materially between the two business models. Expect financial outcomes to cluster around discrete events (IDIQs, FMS awards, test milestones) rather than smooth upgrades.

Second-order winners from a sustained unmanned/autonomy buildout are not just the platform OEMs but domestic propulsion/actuator suppliers, edge-AI accelerators, and high-throughput contract manufacturers able to convert engineering prototypes into 1k+ unit production runs. Conversely, large legacy primes that compete on bespoke integration and long lead-time supply chains will face margin pressure as modular, commodity-like drone subsystems scale. Export controls and end-user vetting will concentrate foreign procurement through a smaller set of approved suppliers, amplifying winner-take-most dynamics for compliant manufacturers.

Key catalysts and time horizons: quarterly results and backlog disclosures (days–weeks), award announcements and production-rate changes (3–12 months), and doctrinal shifts or sustained budget growth that alter unit economics (1–4 years). Principal tail risks are procurement pauses, a single high-profile test failure that triggers program-wide retesting, or a rapid pivot of funding away from tactical unmanned into hypersonics or space that would reallocate capital.

The consensus underweights operational leverage from manufacturing scale and overweights headline EPS volatility; if a supplier demonstrates 2–3x capacity improvement in next 12 months, earnings should re-rate faster than consensus models allow. That creates asymmetric option-style upside for the capacity-ready name and a clearer path to a short/hedge against the name losing contract share during the next award cycle.

Key Decisions for Investors

• Pair trade (6–12 months): go long the execution/production-exposed name (KTOS) and short the discretionary/visibility-constrained name (AVAV) in a 1.5:1 dollar ratio. Target relative outperformance of +30–40%; cut losses if the pair moves against you by 20% relative. Size: 2–4% portfolio net exposure, monitor backlog disclosures weekly.
• Long optionality (12–24 months): buy LEAP calls on the scaled-production beneficiary (e.g., KTOS Jan-2028 30–35% OTM calls). Allocate no more than 2–3% of portfolio — payoff if a multi-year production ramp or export-approved FMS awards materialize; downside limited to premium.
• Protective hedge / volatility play (3–9 months): buy 6-month puts 15–25% OTM on the visibility-constrained name (AVAV) to protect against negative EPS revisions or contract losses. This caps downside for existing long exposure and monetizes event-driven downside risk; cost is limited to premium (expect ~5–8% of notional).
• Thematic overlay (6–12 months): maintain a small (1–2%) long position in AI/edge compute exposure (NVDA call spread 6–9 month) to capture upside if accelerated on-board autonomy increases compute content per vehicle. This acts as a convex hedge to the automation-adoption upside across the sector.